Thoracic Sympathetic Block for Breast Cancer-Related Lymphedema

Thoracic Sympathetic Block for Breast Cancer-Related Lymphedema: Randomized-Controlled Trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0010663

Enrollment

Registered

2025-06-23

Start date

2025-09-12

Completion date

Unknown

Last updated

2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : 1. Patients diagnosed with breast cancer-related lymphedema are randomly assigned to either the experimental group or the placebo control group. 2. Both the experimental and place

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Patients who have undergone mastectomy with sentinel lymph node biopsy or axillary lymph node dissection (2) Patients diagnosed with unilateral breast cancer-related lymphedema classified as stage 1 or 2 according to the International Society of Lymphology (3) Patients who have shown minimal response to conventional conservative treatment

Exclusion criteria

Exclusion criteria: (1) Patients with bilateral breast cancer-related lymphedema (2) Patients with metastatic breast cancer (3) Patients with an allergy to local anesthetics (4) Patients with infection or cellulitis (5) Patients who are receiving anticoagulant therapy or have a coagulation disorder

Design outcomes

Primary

Measure	Time frame
Change in volume difference between the affected and contralateral upper limbs	—

Secondary

Measure	Time frame
Change in volume difference between the affected and contralateral upper limbs, changes in affected-arm volume, and Lymphedema and Breast Cancer Questionnaire scores.	—

Countries

Korea, Republic of

Contacts

Public ContactJaeho Cho

Seoul National University Bundang Hospital

jaehotv@gmail.com+82-31-219-6436

Outcome results